Minireviews
Copyright ©The Author(s) 2022.
World J Hepatol. Feb 27, 2022; 14(2): 338-353
Published online Feb 27, 2022. doi: 10.4254/wjh.v14.i2.338
Table 3 Uses of available cytomegalovirus assays
Use
Assay
DiagnosisCMV viral load by plasma QNAT; CMV viral load by real-time PCR assay; pp65 antigen testing; CMV IgG/IgM antibodies
Diagnosis of tissue-invasive CMV diseaseHistopathology
Pre-transplant risk stratificationCMV IgG/IgM antibodies
Threshold for initiation of pre-emptive therapyCMV viral load by plasma QNAT; Quantitative pp65 antigen measurement; NASBA assay
Monitoring or endpoint (prophylaxis, pre-emptive or treatment)CMV viral load by plasma QNAT; QuantiFERON-CMV assay
Endpoint of treatment of tissue-invasive CMV diseaseHistopathology
Prediction of developing CMV diseaseQuantiFERON-CMV assay